David’s practice addresses both regulatory and transactional aspects of healthcare services transactions, joint ventures, and strategic partnerships. He goes beyond the typical role of a deal lawyer by focusing on the long-term success of organizations post-transaction, considering factors like physician alignment, compliance, and reimbursement early in negotiations. He has advised a variety of healthcare service providers, including Northwell Health, Crouse Hospital, Maimonides Medical Center, U.S. Renal Care, and major academic medical centers, helping them achieve growth and expansion goals.
David also advises private equity firms, including The Riverside Company, Quad-C Management, Beecken Petty O’Keefe & Company, Iron Path Capital, and Deerfield Management, on complex transactions. He is highly sought after for his expertise in operational and management matters within healthcare’s intricate regulatory environment, particularly in the areas of affiliations, mergers and acquisitions, fraud and abuse, compliance programs, reimbursement, and corporate practice of medicine issues.
Before practicing law, David was a surgeon specializing in foot and ankle reconstruction, with a subspecialty in treating osteomyelitis of the lower extremity. He completed his residency at St. Joseph’s Hospital in Philadelphia and an AO Fellowship in reconstructive surgery and infection treatment in Ravensburg, Germany.
David frequently speaks on healthcare private equity issues alongside investment bankers and senior executives, providing insight that bridges the financial and legal aspects of sophisticated healthcare transactions.